- Physicians read only the abstract of a publication 63% of the time. At the same time, 45% of HCPs are unreachable through conventional digital outreach.
- 82% of pharma teams believe their outreach works. Only 28% of physicians agree. What gets watched tends to get understood.
- One MLR review covers every journey built from that core. From that same core, teams have taken one approved story across many markets without restarting the scientific review each time.
A handful of confirmed numbers explain why video keeps outperforming static pharma content. Here's what we found, and what it means for how you build your next story.
01Start with the reading problem
Physicians read only the abstract of a publication 63% of the time. At the same time, 45% of HCPs are unreachable through conventional digital outreach altogether.
of the time, physicians read only the abstract of a publication, not the full paper.
MLR review covers every version, however many journeys one approved core holds.
languages one approved core is produced in, without restarting the scientific review each time.
Every figure here is independently sourced.
02The gap between confidence and reality
82% of pharma teams believe their outreach works. Only 28% of physicians agree. What gets watched tends to get understood, and what gets understood is what changes a conversation with a patient.
“Rigor was never the bottleneck, format was. A publication that's accurate but unread helps nobody.”
03What one approved video actually buys you
One MLR review covers every journey built from that core. From that same core, teams have taken one approved story into 30+ languages without restarting the scientific review for each version.
04Reading the numbers honestly
None of these statistics say video is a shortcut around rigor. Rigor was never the bottleneck, format was. A publication that's accurate but unread helps nobody.